once a week insulin drug, page-8

Hi Dougal -

I can assure you that TPM Insulin is still POHs lead compound.

It is the Big Kahuna in our Pipeline and a blockbuster company maker. It is why many of us became investors in POH and remain loyal to this Biotech.

It is of course a long term project to see a finished consumer ready product. It is also the most expensive drug to take thru trials in our pipleine and will require a Pharma partner to finance it thru the final stages in the clinic. But keep the faith in POHs clinical and deal making abilities. A deal on this can be done at any stage from now - the value of the deal obviously increases as the risk of failure in the clinic reduces- so the further we can advance our trials the better our return will be.

But dont be surprised to see it spun out into its own entity...this could be sooner than you think - Remember Insulpatch?

KC